Core Viewpoint - A class action securities lawsuit has been filed against 3D Systems Corporation, alleging securities fraud that negatively impacted investors between August 13, 2024, and May 12, 2025 [1][2]. Group 1: Allegations - The lawsuit claims that 3D Systems Corporation made false statements regarding the impact of weakened customer spending on its business and overstated its resilience in challenging industry conditions [2]. - It is alleged that updated milestone criteria in the partnership with United Therapeutics Corporation would adversely affect the revenue from the Company's regenerative medicine program [2]. - As a result, the Company's public statements were materially false and misleading throughout the relevant period [2]. Group 2: Legal Process - Investors who suffered losses during the specified timeframe have until August 12, 2025, to request to be appointed as lead plaintiff in the case [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4].

Core Viewpoint - A class action securities lawsuit has been filed against DoubleVerify Holdings, Inc. alleging securities fraud affecting investors between November 10, 2023, and February 27, 2025 [1] Group 1: Allegations of the Lawsuit - The lawsuit claims that DoubleVerify's customers are shifting ad spending from open exchanges to closed platforms, limiting the company's technological capabilities and increasing competition from platforms like Meta and Amazon [2] - It is alleged that DoubleVerify's ability to monetize its Activation Services is constrained due to the high costs and time required for technology development for closed platforms [2] - The complaint states that monetization of DoubleVerify's Activation Services on certain closed platforms could take several years [2] - Competitors are reportedly better positioned to integrate AI into their offerings on closed platforms, negatively impacting DoubleVerify's competitive edge and profitability [2] - The company is accused of systematically overbilling customers for ad impressions served to declared bots from known data center server farms [2] - The risk disclosures provided by DoubleVerify are claimed to be materially false and misleading, presenting adverse facts as mere possibilities [2] - As a result of these issues, the lawsuit asserts that the positive statements made by the defendants regarding the company's business and prospects were materially false or lacked a reasonable basis [2] Group 2: Next Steps for Affected Investors - Investors who suffered losses in DoubleVerify Holdings, Inc. during the specified timeframe have until July 21, 2025, to request appointment as lead plaintiff [3] - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3] Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [4] - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4]

NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Sarepta Therapeutics, Inc. ("Sarepta" or the "Company") (NASDAQ: SRPT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Sarepta investors who were adversely affected by alleged securities fraud between June 22, 2023 and June 24, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/sarepta-lawsuit-submi ...

NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Fortrea Holdings Inc. ("Fortrea Holdings Inc." or the "Company") (NASDAQ: FTRE) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Fortrea Holdings Inc. investors who were adversely affected by alleged securities fraud between July 3, 2023 and February 28, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/psl ...

Core Viewpoint - A class action securities lawsuit has been filed against Petco Health and Wellness Company, Inc. for alleged securities fraud affecting investors between January 14, 2021, and June 5, 2025 [1] Group 1: Lawsuit Details - The lawsuit claims that Petco's pandemic-related advantages were not sustainable and that its business model focused on premium pet food was flawed [2] - It is alleged that the strength of Petco's differentiated product strategy was overstated, and the true scope of issues was downplayed by the defendants [2] - Defendants are accused of overstating Petco's ability to achieve sustainable, profitable growth, leading to materially false and misleading public statements [2] Group 2: Next Steps for Investors - Investors who suffered losses in Petco during the specified timeframe have until August 29, 2025, to request appointment as lead plaintiff, although participation does not require this [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the U.S. [4]

NEW YORK, July 11, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Organon & Co. (NYSE: OGN) between November 3, 2022 and April 30, 2025, both dates inclusive (the "Class Period"), of the important July 22, 2025 lead plaintiff deadline.So what: If you purchased Organon securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.What to do next:  ...

SAN DIEGO, July 11, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP is investigating whether RxSight, Inc. (NASDAQ: RXST), or any of its executive officers, violated federal securities laws by making false or misleading statements or failing to disclose material information to investors. What if I purchased RXST securities?If you purchased RxSight securities and suffered losses on your investment, you may be eligible to participate in our investigation. To join, please click here: ...

NEW YORK, July 11, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Sarepta Therapeutics, Inc. ("Sarepta" or the "Company") (NASDAQ: SRPT) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Sarepta investors who were adversely affected by alleged securities fraud between June 22, 2023 and June 24, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/sarepta-lawsuit-submission- ...

Core Viewpoint - A class action securities lawsuit has been filed against Krispy Kreme, Inc. due to alleged securities fraud affecting investors between March 26, 2024, and May 7, 2025 [1] Group 1: Lawsuit Details - The lawsuit claims that Krispy Kreme's management provided overly positive statements while concealing negative facts about the demand for its products at McDonald's locations [2] - It was revealed that lower demand at McDonald's contributed to a decline in average weekly sales per store, and the partnership with McDonald's was not profitable, leading to a pause in expansion [2] - Krispy Kreme reported a net revenue decline of $404 million, a decrease of 10.4%, and a drop in average sales per door per week due to changing customer mix [2] Group 2: Financial Impact - Following the release of disappointing fourth quarter 2024 results, Krispy Kreme's stock price fell from $9.13 to $7.13 per share [2] - In the first quarter of 2025, the company reported net revenue of $375.2 million, a decline of 15.3% or $67.5 million, and announced a reassessment of its partnership with McDonald's [2] - On May 8, 2025, the stock price dropped from $4.33 to $3.26 per share, a decline of approximately 25% in one day [2] Group 3: Next Steps for Investors - Investors who suffered losses during the relevant time frame have until July 15, 2025, to request to be appointed as lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 4: Legal Representation - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years [4] - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4]

NEW YORK, July 11, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in iRobot Corporation ("iRobot Corporation" or the "Company") (NASDAQ: IRBT) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of iRobot Corporation investors who were adversely affected by alleged securities fraud between January 29, 2024 and March 11, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/irobot-co ...